Andrew Saik

2018 - Edge Therapeutics

In 2018, Andrew Saik earned a total compensation of $1.3M as Chief Financial Officer at Edge Therapeutics, a 23% decrease compared to previous year.

Compensation breakdown

Bonus$166,500
Option Awards$660,490
Salary$370,000
Stock Awards$70,632
Total$1,267,622

Saik received $660.5K in option awards, accounting for 52% of the total pay in 2018.

Saik also received $166.5K in bonus, $370K in salary and $70.6K in stock awards.

Rankings

In 2018, Andrew Saik's compensation ranked 8,008th out of 14,244 executives tracked by ExecPay. In other words, Saik earned more than 43.8% of executives.

ClassificationRankingPercentile
All
8,008
out of 14,244
44th
Division
Manufacturing
3,148
out of 5,759
45th
Major group
Chemicals And Allied Products
1,173
out of 2,122
45th
Industry group
Drugs
985
out of 1,811
46th
Industry
Pharmaceutical Preparations
765
out of 1,385
45th
Source: SEC filing on August 15, 2019.

Saik's colleagues

We found four more compensation records of executives who worked with Andrew Saik at Edge Therapeutics in 2018.

2018

Brian Leuthner

Edge Therapeutics

Chief Executive Officer

2018

W Middlekauff

Edge Therapeutics

General Counsel

2018

Herbert Faleck

Edge Therapeutics

Chief Medical Officer

2018

R Macdonald

Edge Therapeutics

Chief Scientific Officer

News

In-depth

You may also like